Autocrine Loop Involving IL-6 Family Member LIF, LIF Receptor, and STAT4 Drives Sustained Fibroblast Production of Inflammatory Mediators
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
SUMMARY Fibroblasts are major contributors to and regulators of inflammation and dominant producers of interleukin‐6 (IL‐6) in inflammatory diseases like rheumatoid arthritis. Yet, compared to leukocytes, the regulation of inflammatory pathways in fibroblasts is largely unknown. Here, we report that analyses of genes coordinately upregulated with IL‐6 pointed to STAT4 and leukemia inhibitory factor (LIF) as potentially linked. Gene silencing revealed that STAT4 was required for IL‐6 transcription. STAT4 was recruited to the IL‐6 promoter after fibroblast activation, and LIF receptor (LIFR) and STAT4 formed a molecular complex that, together with JAK1 and TYK2 kinases, controlled STAT4 activation. Importantly, a positive feedback loop involving autocrine LIF, LIFR, and STAT4 drove sustained IL‐6 transcription. Besides IL‐6, this autorine loop also drove the production of other key inflammatory factors including IL‐8, granulocyte‐colony stimulating factor (G‐CSF), IL‐33, IL‐11, IL‐1&agr;, and IL‐1&bgr;. These findings define the transcriptional regulation of fibroblast‐mediated inflammation as distinct from leukocytes. Graphical Abstract Figure. No Caption available. HighlightsDuring inflammation, human fibroblasts upregulate LIF and STAT4LIF acts in an autocrine manner via LIF receptor to promote STAT4 activationActivated STAT4 together with NF‐&kgr;B/p65‐p52 and C/EBP&bgr; enhances IL‐6 transcriptionLIFR/STAT4 circuit also regulates IL‐8, G‐CSF, IL‐33, IL‐11, IL‐1&agr;, and IL‐1&bgr; &NA; Growing evidence implicates fibroblasts as inflammatory cells in sites of peripheral inflammation. Nguyen and colleagues demonstrate that regulation of IL‐6 along with a set of other inflammatory cytokines and chemokines is regulated by a positive feedback loop involving LIF, LIF receptor, and STAT4 that selectively operates in fibroblasts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288 · cited 1×
“The microarray data used in this publication have been deposited in NCBI’s Gene Expression Omnibus (Edgar et al., 2002).”
MethodFishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V, Yudkin, J. S., Humphries, S., & Woo, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2629 · Cited by 2,243 · cited 1×
“Genetic studies have implicated IL-6 alleles in the predisposition to several autoimmune disorders (Fishman et al., 1998; Lee et al., 2012; Li et al., 2014; Villuendas et al., 2002).”
BackgroundSuppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–α
Kraman, M., Bambrough, P. J., Arnold, J. N., Roberts, E. W., Magiera, L., Jones, J. O., Gopinathan, A., Tuveson, D. A., & Fearon, D. T. (2010) · Science · doi:10.1126/science.1195300 · Cited by 1,134 · cited 1×
“In tumor tissues, fibroblasts referred to as stromal cells can profoundly inhibit anti-tumor immune responses that are reactivated upon removal of the inhibitory stromal cells (Kraman et al., 2010).”
BackgroundHoussiau, F. A., Devogelaer, J., Damme, J. V., Deuxchaisnes, C. N. D., & Snick, J. V. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310614 · Cited by 847 · cited 1×
“In rheumatoid arthritis (RA) patients, the joint fluids and plasma contain high concentrations of IL-6 and synovial and serum amounts of IL-6 correlate with RA disease activity (Hirano et al., 1988; Houssiau et al., 1988; Madhok et al., 1993).”
BackgroundExcessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis
Hirano, T., Matsuda, T., Turner, M., Miyasaka, N., Buchan, G., Tang, B., Sato, K., Shimi, M., Maid, R., Feldmann, M., et al. (1988) · European Journal of Immunology · doi:10.1002/eji.1830181122 · Cited by 784
Interleukin-6 and its receptors: a highly regulated and dynamic system
Wolf, J., Rose-John, S., & Garbers, C. (2014) · Cytokine · doi:10.1016/j.cyto.2014.05.024 · Cited by 618 · cited 2×
“…such as rheumatoid arthritis, Crohn’s disease, systemic lupus erythematosus, Castleman’s disease, Behcet’s disease, and systemic juvenile idiopathic arthritis as well as in coronary artery and neurologic diseases and in neoplasms (Hong et al., 2007; Waldner and Neurath, 2014; Wolf et al., 2014).”
BackgroundOgura, H., Murakami, M., Okuyama, Y., Tsuruoka, M., Kitabayashi, C., Kanamoto, M., Nishihara, M., Iwakura, Y., & Hirano, T. (2008) · Immunity · doi:10.1016/j.immuni.2008.07.018 · Cited by 564
Interleukin‐6 and its receptor in cancer: Implications for Translational Therapeutics
Hong, D. S., Angelo, L. S., & Kurzrock, R. (2007) · Cancer · doi:10.1002/cncr.22999 · Cited by 370
Ruddy, M. J., Wong, G. C., Liu, X. K., Yamamoto, H., Kasayama, S., Kirkwood, K. L., & Gaffen, S. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308809200 · Cited by 364 · cited 1×
“ELF3 and CEBPD TFs have previously been implicated in IL-6 expression in murine dendritic and osteoblastic cells (Kushwah et al., 2011; Ruddy et al., 2004).”
BackgroundMadhok, R., Crilly, A., Watson, J., & Capell, H. A. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.3.232 · Cited by 340
Lymph node stroma broaden the peripheral tolerance paradigm
Fletcher, A. L., Malhotra, D., & Turley, S. J. (2011) · Trends in Immunology · doi:10.1016/j.it.2010.11.002 · Cited by 120 · cited 1×
“After microbial antigens from peripheral tissues elicit immune responses, the FRCs in lymph nodes produce nitric oxide and surface inhibitory receptors that help dampen and terminate T cell responses (Fletcher et al., 2011).”
BackgroundLi, F., Xu, J., Zheng, J., Sokolove, J., Zhu, K., Zhang, Y., Sun, H., Evangelou, E., & Pan, Z. (2014) · Scientific Reports · doi:10.1038/srep05714 · Cited by 48 · cited 1×
“Genetic studies have implicated IL-6 alleles in the predisposition to several autoimmune disorders (Fishman et al., 1998; Lee et al., 2012; Li et al., 2014; Villuendas et al., 2002).”
Background
Cited by
Accelerating Medicines Partnership Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA/SLE) Consortium, Zhang, F., Wei, K., Slowikowski, K., Fonseka, C. Y., Rao, D. A., Kelly, S., Goodman, S. M., Tabechian, D., Hughes, L. B., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0378-1 · Cited by 1,367
Self-citationEvolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
Xue, C., Yao, Q., Gu, X., Shi, Q., Yuan, X., Chu, Q., Bao, Z., Lu, J., & Li, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01468-7 · Cited by 699
Fibroblasts as immune regulators in infection, inflammation and cancer
Davidson, S., Coles, M., Thomas, T., Kollias, G., Ludewig, B., Turley, S., Brenner, M., & Buckley, C. D. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00540-z · Cited by 605
Self-citationPleiotropy and specificity: insights from the interleukin 6 family of cytokines
Murakami, M., Kamimura, D., & Hirano, T. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.027 · Cited by 533
Notch signalling drives synovial fibroblast identity and arthritis pathology
Wei, K., Korsunsky, I., Marshall, J. L., Gao, A., Watts, G. F. M., Major, T., Croft, A. P., Watts, J., Blazar, P. E., Lange, J. K., et al. (2020) · Nature · doi:10.1038/s41586-020-2222-z · Cited by 528
Self-citation
Metadata
- Authors
- Nguyen, H. N., Noss, E. H., Mizoguchi, F., Huppertz, C., Wei, K. S., Watts, G. F. M., & Brenner, M. B.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2017-02
- Volume
- 46
- Issue
- 2
- Pages
- 220-232
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2590221407
- Cited by
- 209
- References
- 12
- FWCI
- 4.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.